Ads
related to: side effects of kadcyla- ENHERTU Dosing
Find ENHERTU Dosing & Admin
Resources For Your Practice.
- Downloadable Resources
Access ENHERTU Downloadable
Resources For Your Patients.
- Efficacy & Safety Data
Learn More About The
Efficacy & Safety Data For ENHERTU.
- ENHERTU Clinical Data
Visit To View Important ENHERTU
Clinical Data For Your Practice.
- Access & Support
View Helpful Patient Support Info
On The Official HCP Website.
- ENHERTU Information
Visit To Learn More About
ENHERTU For Your Practice.
- ENHERTU Dosing
Search results
'I'm a people lover': Cancer patient volunteers for clinical trials to help others
Savannah Morning News via Yahoo News· 7 months agoCancer care is constantly improving at Lewis Cancer Research Pavilion and clinical trial...
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout
BioPharma Dive via Yahoo Finance· 6 months agoAbbVie is expanding its investment in targeted cancer medicines, announcing Thursday a $10.1 billion...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 6 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
What Are Biologics?
Health via Yahoo News· 6 months agoThe term “biologic” refers to a wide group of therapies used to treat many different types of medical conditions, such as rheumatoid arthritis and...
An Important History Lesson for Gene-Editing Investors
Motley Fool· 6 months agoThe history of biotechnology is full of examples of promising technologies that took decades to...
How This Multibillion-Dollar Company Is Shaking Off the Competition
Motley Fool· 2 years agoThe company hopes to reverse the trend with a bunch of new product launches and a more diversified portfolio. Last week's earnings release shows some positive signs for the company going forward ...
Merck's Deal With Seagen May Have Fallen Through. Now What?
Motley Fool· 2 years agoFollowing months of speculation over pharmaceutical giant Merck's (NYSE: MRK) potential takeover of cancer-focused biotech Seagen (NASDAQ: SGEN), reports are now surfacing that the two companies ...